Clinical Trial Update: Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating bevacizumab (Avastin) in epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer; the study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Ovarian Cancer, Primary Peritoneal Serous Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-11-25